Actos (pioglitazone) reduces the risk of heart attack, stroke, and death in some patients with type 2 diabetes

October 2005

New evidence shows that Actos (pioglitazone) reduces the risk of heart attack, stroke, and death in some patients with type 2 diabetes.

We know that improving glycemic control reduces the risk of MICROvascular complications...retinopathy, nephropathy, neuropathy.

But there are questions about whether improving glycemic control reduces MACROvascular complications...heart attack and stroke.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

a lot for all of us to learn from hurricanes Katrina and Rita
Diabetes Actos (pioglitazone) reduces the risk of heart attack, stroke, and death in some patients with type 2 diabetes
Infectious Diseases shorter five-day regimen of levofloxacin (Leva-pak) for acute bacterial sinusitis
Interactions potentially fatal interaction between colchicine and some macrolides
Dyslipidemia Omacor, the first PRESCRIPTION omega-3 fatty acid product
Women's Health whether paroxetine (Paxil) increases the risk of birth defects
Colon Cancer You'll see new home-screening tests for colon cancer
Mirapex for fibromyalgia
More patients will be treated with buprenorphine for opioid addiction
Cardiology Viagra does NOT seem to increase the risk of heart attack in most men
Cardiology whether heart attack patients should get a statin IMMEDIATELY
Cardiology Stopping aspirin even short-term may increase the risk of heart attack and stroke
Dermatology what works for diaper rashes
doxycycline for OSTEOarthritis
Insomnia Ambien CR, a new extended-release zolpidem for insomnia